Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anagrelide-induced cardiomyopathy.

C W James1

  • 1Department of Pharmacy Services, Baylor University Medical Center, Dallas, Texas 75246, USA.

Pharmacotherapy
|October 18, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A luminous fast radio burst that probes the Universe at redshift 1.

Science (New York, N.Y.)·2023
Same author

A census of baryons in the Universe from localized fast radio bursts.

Nature·2020
Same author

A single fast radio burst localized to a massive galaxy at cosmological distance.

Science (New York, N.Y.)·2019
Same author

The dispersion-brightness relation for fast radio bursts from a wide-field survey.

Nature·2018
Same author

An algorithm for the reconstruction of high-energy neutrino-induced particle showers and its application to the ANTARES neutrino telescope.

The European physical journal. C, Particles and fields·2017
Same author

Sperm whale long-range echolocation sounds revealed by ANTARES, a deep-sea neutrino telescope.

Scientific reports·2017
Same journal

The Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of a Single Oral Dose of Zongertinib in Healthy Male Volunteers.

Pharmacotherapy·2026
Same journal

Menopausal Hormone Therapy: A Narrative Review of Contemporary Evidence.

Pharmacotherapy·2026
Same journal

Getting It Right the Second Time: How Can we Optimize First-Generation Cephalosporin Dosing for Skin and Soft Tissue Infections in the 21st Century?

Pharmacotherapy·2026
Same journal

Buprenorphine Initiation During Extracorporeal Membrane Oxygenation Decreases Sedative and Opioid Exposure: A Retrospective Matched Case-Control Study.

Pharmacotherapy·2026
Same journal

Voriconazole Dosing and Therapeutic Drug Monitoring in Patients Before and After Liver Transplantation.

Pharmacotherapy·2026
Same journal

Quantifying the Serum Magnesium Response and Predictors of Response Following Intravenous Magnesium Replacement in Critically Ill Patients.

Pharmacotherapy·2026
See all related articles

Anagrelide, used for hematologic disorders, may cause serious heart problems like congestive heart failure. This case report highlights potential cardiovascular risks associated with anagrelide therapy.

Area of Science:

  • Cardiology
  • Hematology
  • Pharmacology

Background:

  • Anagrelide is a medication used to treat hematologic disorders.
  • Cardiovascular events have been reported with anagrelide use.
  • The drug's mechanism may involve phosphodiesterase inhibition, leading to positive inotropic effects and vasodilation.

Observation:

  • A 48-year-old woman with polycythemia vera experienced cardiotoxicity.
  • Symptoms included congestive heart failure and palpitations.
  • These events were suspected to be linked to anagrelide dosage adjustments.

Findings:

  • The patient developed congestive heart failure and palpitations.
  • Cardiotoxicity was temporally associated with anagrelide titration.
  • This suggests a potential causal relationship between anagrelide and cardiovascular adverse events.

Related Experiment Videos

Implications:

  • Clinicians should be aware of the potential cardiotoxicity of anagrelide.
  • Monitoring for cardiovascular symptoms is crucial in patients treated with anagrelide.
  • Further research is needed to fully understand and manage anagrelide-induced cardiotoxicity.